These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17348446)
41. How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer? Tempfer CB; Hefler LA; Schneeberger C; Huber JC Gynecol Endocrinol; 2006 Mar; 22(3):155-9. PubMed ID: 16835078 [TBL] [Abstract][Full Text] [Related]
42. Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibility. Lattrich C; Müller AK; Schüler S; Häring J; Ruoff A; Treeck O; Ortmann O Oncol Rep; 2012 Sep; 28(3):1091-5. PubMed ID: 22710726 [TBL] [Abstract][Full Text] [Related]
43. Birth weight, breast cancer susceptibility loci, and breast cancer risk. Tamimi RM; Lagiou P; Czene K; Liu J; Ekbom A; Hsieh CC; Adami HO; Trichopoulos D; Hall P Cancer Causes Control; 2010 May; 21(5):689-96. PubMed ID: 20054709 [TBL] [Abstract][Full Text] [Related]
44. Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk. Cox DG; Hankinson SE; Hunter DJ Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):178-9. PubMed ID: 16434609 [No Abstract] [Full Text] [Related]
45. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Wagner K; Hemminki K; Försti A Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888 [TBL] [Abstract][Full Text] [Related]
46. A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene. Lourenço GJ; Cardoso-Filho C; Gonçales NS; Shinzato JY; Zeferino LC; Nascimento H; Costa FF; Gurgel MS; Lima CS Breast Cancer Res Treat; 2006 Dec; 100(3):335-8. PubMed ID: 16807676 [TBL] [Abstract][Full Text] [Related]
47. Association between the -402GA, -401GT, and -323ins10-bp polymorphisms of factor VII gene and breast cancer. Eroğlu A; Oztürk A; Akar N Breast Cancer; 2011 Oct; 18(4):282-5. PubMed ID: 20107938 [TBL] [Abstract][Full Text] [Related]
48. Single nucleotide polymorphisms and breast cancer: not yet a success story. Tamimi RM Breast Cancer Res; 2006; 8(4):108. PubMed ID: 16887007 [TBL] [Abstract][Full Text] [Related]
49. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. Frank B; Bermejo JL; Hemminki K; Klaes R; Bugert P; Wappenschmidt B; Schmutzler RK; Burwinkel B J Natl Cancer Inst; 2005 Jul; 97(13):1012; author reply 1012-3. PubMed ID: 15998955 [No Abstract] [Full Text] [Related]
50. Association of metabolism-related genes polymorphisms with adenocarcinoma of the oesophagogastric junction: Evidence from 2261 subjects. Tang W; Liu J; Zhong Z; Qiu H; Kang M J Cell Biochem; 2019 Nov; 120(11):18689-18701. PubMed ID: 31211453 [TBL] [Abstract][Full Text] [Related]
51. Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis. Park B; Shin A; Kim KZ; Lee YS; Hwang JA; Kim Y; Sung J; Yoo KY; Lee ES Asian Pac J Cancer Prev; 2014; 15(21):9093-9. PubMed ID: 25422184 [TBL] [Abstract][Full Text] [Related]
52. Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study. Saracevic A; Nikolac N; Reljic A; Simundic AM Genet Test Mol Biomarkers; 2011 Mar; 15(3):127-31. PubMed ID: 21204696 [TBL] [Abstract][Full Text] [Related]
53. PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk. Martínez-Nava GA; Burguete-García AI; López-Carrillo L; Hernández-Ramírez RU; Madrid-Marina V; Cebrián ME Biomarkers; 2013 Sep; 18(6):493-501. PubMed ID: 23866026 [TBL] [Abstract][Full Text] [Related]
54. Polymorphisms of short tandem repeat of genes and breast cancer susceptibility. Zhang W; Yu YY Eur J Surg Oncol; 2007 Jun; 33(5):529-34. PubMed ID: 17215102 [TBL] [Abstract][Full Text] [Related]
55. A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. Barrdahl M; Canzian F; Gaudet MM; Gapstur SM; Trichopoulou A; Tsilidis K; van Gils CH; Borgquist S; Weiderpass E; Khaw KT; Giles GG; Milne RL; Le Marchand L; Haiman C; Lindström S; Kraft P; Hunter DJ; Ziegler R; Chanock SJ; Yang XR; Buring JE; Lee IM; Kaaks R; Campa D Int J Cancer; 2018 Mar; 142(6):1182-1188. PubMed ID: 29114882 [TBL] [Abstract][Full Text] [Related]
56. Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. Ioannidis JP J Natl Cancer Inst; 2006 Oct; 98(19):1350-3. PubMed ID: 17018776 [No Abstract] [Full Text] [Related]
57. No association between BRCA2 N372H and breast cancer risk. Cox DG; Hankinson SE; Hunter DJ Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1353-4. PubMed ID: 15894703 [No Abstract] [Full Text] [Related]
58. Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. Prentice RL; Qi L Biostatistics; 2006 Jul; 7(3):339-54. PubMed ID: 16443924 [TBL] [Abstract][Full Text] [Related]
59. CD40 -1C>T single nucleotide polymorphism and CD40 expression on breast tumors. Dolen Y; Yilmaz G; Esendagli G; Guler NE; Guc D Cytokine; 2010 Jun; 50(3):243-4. PubMed ID: 20371189 [No Abstract] [Full Text] [Related]
60. Centrosome-related genes, genetic variation, and risk of breast cancer. Olson JE; Wang X; Pankratz VS; Fredericksen ZS; Vachon CM; Vierkant RA; Cerhan JR; Couch FJ Breast Cancer Res Treat; 2011 Jan; 125(1):221-8. PubMed ID: 20508983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]